Basic Information
ID: ALA4309312
Type: Functional
Description: Antitumor activity against human IGROV1 cells xenografted in NCR SCID mouse assessed as median tumor burden at 95 mg/kg, iv treated once daily for 4 days per week for 4 weeks starting from 3 days post implantation and measured at day 60 post last dose (Rvb = 108 mg)
Organism: Homo sapiens
Cell type: IGROV-1
Activity Charts
Bioactivity
Activity Types for Assay ALA4309312
Activity
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 479.49 | 1.65 | 1.65 |